Autor: |
Shimizu M; Hematology and Oncology Division, Hitachi General Hospital., Tsuboi Y; Hematology and Oncology Division, Hitachi General Hospital., Kuroda A; Hematology and Oncology Division, Hitachi General Hospital., Seki M; Hematology and Oncology Division, Hitachi General Hospital., Shinagawa A; Hematology and Oncology Division, Hitachi General Hospital. |
Jazyk: |
japonština |
Zdroj: |
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2024; Vol. 65 (6), pp. 487-491. |
DOI: |
10.11406/rinketsu.65.487 |
Abstrakt: |
Here we describe the case of a 69-year-old man who was found to have moderate thrombocytopenia and severe splenomegaly during a medical checkup at the age of 67. At the first visit, his white blood cell (WBC) count was 7,400/µl with 80% lymphocytes, and bone marrow aspiration showed 24% atypical lymphocytes. Flow cytometry of atypical lymphocytes was positive for mature T-cell markers, and T-cell clonality was revealed by T-cell receptor gene rearrangement. TCL1 was negative on immunohistochemistry. We diagnosed TCL1-family negative T-cell prolymphocytic leukemia (T-PLL) and employed watchful waiting. Thirty months after diagnosis, the patient developed urinary retention and right lower-limb paresis despite a normal WBC count, and an extradural tumor around the thoracic vertebrae and spinal cord compression were detected. The tumor was diagnosed as extranodal involvement of TCL1-family negative T-PLL, but the patient's general condition deteriorated rapidly, and no treatment was possible. T-PLL is a rare disease characterized by leukocytosis, and the WBC count generally increases with disease progression. Although blood counts are recommended for observation, it is important to keep in mind that the disease may worsen even if blood counts do not change. |
Databáze: |
MEDLINE |
Externí odkaz: |
|